Update to revenue guidance

RNS Number : 7751R
Oxford Nanopore Technologies plc
09 November 2021
 

ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE UK VERSION OF THE MARKET ABUSE REGULATION (EU NO. 596/2014) WHICH FORMS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

9 November 2021

 

Oxford Nanopore Technologies plc

Update to revenue guidance following expansion of customer project

 

Oxford Nanopore Technologies plc (the "Group"), the company behind a new generation of nanopore-based sensing technology, is updating its revenue guidance following a significant expansion of the Group's activities in a large customer project in UAE.

 

On 9 November 2021, the Group was awarded a new 36-month contract under which it will provide devices, consumables including flow cells and kits, and other support services worth approximately US$68 million.

 

The new contract with G42 Laboratory, LLC, who provide sequencing operations in the project, is expected to generate revenues primarily after the year ended 31 December 2021 ("FY21"). Therefore, the Group is maintaining its guidance of core Life Science Research Tools ("LSRT") revenue of £105-111 million in FY21, resulting from growth of 60-70% as announced on 14 October 2021.

 

Given the scale of the new contract, the Group is now introducing guidance for LSRT revenue of 135-145 million for FY22. The Group is also upgrading its LSRT revenue guidance for FY23 to 170-190 million, compared to its previous expectation of 165 -175 million outlined in its IPO Prospectus.

 

All revenue guidance figures are provided on a constant currency basis.

 

As noted in the IPO Prospectus, an affiliate of G42 Laboratory, LLC, is a shareholder in the Group.

 

Media Enquiries

media@nanoporetech.com

Tulchan Group (communications adviser to the Company)

Tom Murray and Deborah Roney

+44 (0) 20 7353 4200  OxfordNanoporeTechnologies@tulchangroup.com

 

The person responsible for arranging the release of this announcement on behalf of the Company is Hannah Coote, Company Secretary of Oxford Nanopore Technologies plc.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKZMGMVLRGMZG
UK 100

Latest directors dealings